Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00389090
Status:
TERMINATED
Last Update Posted:
2012-02-09
First Post:
2006-10-16
Brief Title:
A Phase II Study of Temozolomide and O6-Benzylguanine O6-BG in Patients With Temozolomide-Resistant Anaplastic Glioma
Sponsor:
Keryx AOI Pharmaceuticals Inc
Organization:
Keryx AOI Pharmaceuticals Inc